Centene: Why The ACA Subsidy Won't Reach 2027, And What Will
Summary Centene is rated Hold with a fair value of $74, modestly above its current price, reflecting limited upside. The post-election rally was premature; enhanced ACA subsidies are unlikely to impact CNC's 2027 earnings, as Marketplace margins have already recovered via pricing. Medicaid, over half of CNC's revenue, is the…